
Novo Nordisk Wins Legal Battle Regarding Compounded Semaglutide
A Texas federal court ruled in favor of Novo Nordisk and FDA, denying a compounding trade association's motion to freeze the FDA's decision to end the shortage of semaglutide injectable medicines. The court's ruling left in place FDA's …